Health and Fitness Health and Fitness
Tue, August 7, 2012
Mon, August 6, 2012
Fri, August 3, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
Tue, July 31, 2012
Mon, July 30, 2012
Sun, July 29, 2012
Fri, July 27, 2012
Thu, July 26, 2012
Wed, July 25, 2012
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
Mon, July 23, 2012
Sun, July 22, 2012
Sat, July 21, 2012
Fri, July 20, 2012
Thu, July 19, 2012
Wed, July 18, 2012
Tue, July 17, 2012
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
30 a.m. ET
Fri, July 13, 2012
Thu, July 12, 2012
Wed, July 11, 2012

Acura Pharmaceuticals to Host Second Quarter 2012 Financial Results Conference Call on August 8, 2012


//health-fitness.news-articles.net/content/2012/ .. al-results-conference-call-on-august-8-2012.html
Published in Health and Fitness on Wednesday, July 25th 2012 at 4:20 GMT by Market Wire   Print publication without navigation


July 25, 2012 07:00 ET

Acura Pharmaceuticals to Host Second Quarter 2012 Financial Results Conference Call on August 8, 2012

PALATINE, IL--(Marketwire - Jul 25, 2012) -  Acura Pharmaceuticals, Inc. (NASDAQ: [ ACUR ]), a specialty pharmaceutical company innovating [ abuse deterrent drugs ], today announced that the company plans to report financial results for the second quarter of 2012 following the close of financial markets on Tuesday, August 7, 2012. The company will host a conference call to discuss the results on Wednesday, August 8, 2012 at 8:30 a.m. ET.

To participate in the live conference call, please dial 800-967-7140 (U.S. and Canada) or 719-457-2632 (international) five to ten minutes prior to the start of the call. The participant passcode is 8419237. A live audio webcast will also be available through the "[ Investors ]" section of the company's website, [ http://www.acurapharm.com ].

A replay of the call will be available beginning August 8, 2012 at 11:30 a.m. ET and ending on August 22, 2012 on the company's website, and by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820 (international). The replay participant code is 8419237.

About Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address [ medication abuse and misuse ], utilizing its proprietary AVERSION® and IMPEDE™ technologies. In June 2011, the U.S. Food and Drug Administration, or FDA, approved OXECTA® which incorporates the AVERSION technology. The Company has a development pipeline of additional AVERSION technology products including other opioids and it's IMPEDE technology for pseudoephedrine hydrochloride products.



Publication Contributing Sources